Bacteria, superbugs and germs breed in pillows

By Admin
Pillows found in homes and hospitals can act as a breeding ground for infectious germs and superbugs, according to a new study. Illnesses such as MRSA...

Pillows found in homes and hospitals can act as a breeding ground for infectious germs and superbugs, according to a new study.

Illnesses such as MRSA, C.diff, leprosy, influenza and chicken pox find the stuffy air conditions that surround beds and pillows ideal for breeding and multiplying.

Scientists revealed that after being slept on for two years over 30 percent of a pillow is made up of bacteria, dead skin and faeces from dust mites.


To read the latest edition of Healthcare Global, click here

 As part of the study, scientists from St. Barts Hospital looked at the pillows used in hospitals run by the London NHS trust.

Results showed that more than one million Staphylococcus hominus bugs per millilitre were found in many of the hospital pillows.

This is type of bug has the potential to cause severe infection in those patients with already weakened immune systems.   

Dr Arthur Tucker, who headed up the study, said in an interview: “People put a clean pillow case on and it looks and smells nice and fresh, but you are wrapping up something really nasty underneath.”

He described the Staphylococcus hominus bug as a “biohazard” and added: “The presence of these bugs means that they can and will be passed to patients.”

However, it is not just hospital pillows that carry this risk; bacteria can feast on dead skin and multiply on the surface of and in the filling of pillows in the home.  

The researchers compared the results of hospital pillows with a specially designed medical pillow called SleepAngel.   

Developed by Irish company Gabriel Scientific, SleepAngel pillows are made from a membrane designed to keep bacteria out a heart stent.  

These pillows tested negative for any traces of bacteria after two months of use while the standard hospital pillows featured a range of bacteria and micro-organisms.

The findings of the study were discussed at the 2011 Healthcare Associated Infections conference.


Featured Articles

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Itai Hayut, CEO of healthtech company Scopio Labs, on how AI & digitalisation help in the detection of blood related cancers, anaemia & allergies

2023 predictions with Harshit Jain, global CEO of Doceree

Harshit Jain, founder & global CEO of IT service Doceree, offers his 2023 predictions for the healthcare industry on affordability, marketing & telehealth

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19

World Mental Health Day: how parents can help stop bullying

Digital Healthcare

The Taiwan Excellence Award Winners on new technologies

Medical Devices & Pharma